Coexistent Loss of the Expressions of BRCA1 and p53 Predicts Poor Prognosis in Triple-Negative Breast Cancer

被引：0
|
作者：
Min Chong Kim
Jung Eun Choi
Soo Jung Lee
Young Kyung Bae
机构：
[1] Yeungnam University College of Medicine,Department of Pathology
[2] Yeungnam University College of Medicine,Department of Surgery
来源：
Annals of Surgical Oncology | 2016年 / 23卷
关键词：
Breast Cancer; Overall Survival; TP53 Mutation; Hormone Receptor Status; Sporadic Breast Cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3524 / 3530
页数：6
相关论文
共 50 条
  • [31] Mutant p53: A therapeutic target for the treatment of triple-negative breast cancer?
    Synnott, Naoise C.
    Pierce, Aisling
    Mullooly, Maeve
    Caiazza, Francesco
    McGowan, Patricia M.
    O'Donovan, Norma
    Crown, John
    Duffy, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [32] Prevalence of BRCA1 mutations among 284 women with triple-negative breast cancer
    Fostira, F.
    Tsitlaidou, M.
    Gogas, H.
    Pertesi, M.
    Yannoukakos, D.
    Bournakis, E.
    Karavassilis, V.
    Skarlos, P.
    Konstantopoulou, I.
    Fountzilas, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [33] Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer
    Wong-Brown, Michelle W.
    Meldrum, Cliff J.
    Carpenter, Jane E.
    Clarke, Christine L.
    Narod, Steven A.
    Jakubowska, Anna
    Rudnicka, Helena
    Lubinski, Jan
    Scott, Rodney J.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (01) : 71 - 80
  • [34] Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer
    Rummel, Seth
    Varner, Erika
    Shriver, Craig D.
    Ellsworth, Rachel E.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (01) : 119 - 125
  • [35] Correlation between BRCA1 expression and the advanced stage of triple-negative breast cancer
    Irianiwati, Irianiwati
    Gurky, Thela Calcarina
    Anwar, Sumadi Lukman
    Bawono, Rheza Gandi
    Dwianingsih, Ery Kus
    MOLECULAR AND CLINICAL ONCOLOGY, 2025, 22 (04)
  • [36] The prevalence of BRCA1 mutations among young women with triple-negative breast cancer
    SR Young
    Robert T Pilarski
    Talia Donenberg
    Charles Shapiro
    Lyn S Hammond
    Judith Miller
    Karen A Brooks
    Stephanie Cohen
    Beverly Tenenholz
    Damini DeSai
    Inuk Zandvakili
    Robert Royer
    Song Li
    Steven A Narod
    BMC Cancer, 9
  • [37] BRCA1 deficiency in triple-negative breast cancer: Protein stability as a basis for therapy
    Choi, Eun
    Mun, Gil-im
    Lee, Joohyun
    Lee, Hanhee
    Cho, Jaeho
    Lee, Yun-Sil
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 158
  • [38] Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development
    Nikolaienko, Oleksii
    Eikesdal, Hans P.
    Ognedal, Elisabet
    Gilje, Bjornar
    Lundgren, Steinar
    Blix, Egil S.
    Espelid, Helge
    Geisler, Jurgen
    Geisler, Stephanie
    Janssen, Emiel A. M.
    Yndestad, Synnove
    Minsaas, Laura
    Leirvaag, Beryl
    Lillestol, Reidun
    Knappskog, Stian
    Lonning, Per E.
    GENOME MEDICINE, 2023, 15 (01)
  • [39] Prevalence of BRCA1 mutations in women with triple-negative breast cancer: A systematic review
    Tun, N. M.
    Villani, G. M.
    Ong, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [40] The prevalence of BRCA1 mutations among young women with triple-negative breast cancer
    Young, S. R.
    Pilarski, Robert T.
    Donenberg, Talia
    Shapiro, Charles
    Hammond, Lyn S.
    Miller, Judith
    Brooks, Karen A.
    Cohen, Stephanie
    Tenenholz, Beverly
    DeSai, Damini
    Zandvakili, Inuk
    Royer, Robert
    Li, Song
    Narod, Steven A.
    BMC CANCER, 2009, 9
12345